Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan

By sjmartinez • September 22, 2024

Tangri N, Rastogi A, Sofue T. Summary of Research: Dapagliflozin Utilization in Chronic Kidney Disease and Its Real-World Effectiveness Among Patients with Lower Levels of Albuminuria in the USA and Japan. Adv Ther. 2024 Sep 19. doi: 10.1007/s12325-024-02961-3. Epub ahead of print. PMID: 39298075.

Tags: albuminuria, Chronic kidney disease, dapagliflozin, effectiveness, Epidemiology, Nephrology, Publications, SGLT-2i, Urinary albumin-to-creatinine ratio

Interplay of Donor-Recipient Relationship and Donor Race in Living Liver Donation in the United States

Al-Seraji A, Adeyemo S, Gurakar A, Shah R, Bunnapradist S, Lentine KL, Redfield RR 3rd, Gurakar M, Amin AN, Muzaale AD, Humar A, Al Ammary[...]

Intraoperative Mean Arterial Pressure and Postoperative Delayed Graft Function in Kidney Transplantation: Evaluating Three Commonly Used Thresholds

Pongpruksa C, Khampitak N, Chang D, Bunnapradist S, Gritsch H, Xia VW. Intraoperative Mean Arterial Pressure and Postoperative Delayed Graft Function in Kidney Transplantation: Evaluating[...]

The renal function trajectory in clinical trial design: challenges and opportunities

Rosansky S, Glassock R. The renal function trajectory in clinical trial design: challenges and opportunities. Kidney Int. 2024 Oct;106(4):565-568. doi: 10.1016/j.kint.2024.07.023. PMID: 39304271.